← peptides typeshit

HHS sends peptide interim access plan to the White House for review

Sources say the policy would let compounding pharmacies make popular peptides like BPC-157 without FDA enforcement, despite agency scientists' safety doubts.

Read at STAT

Recap by typeshit. Full story at STAT.